Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Entero Therapeutics (ENTO) has provided an announcement.
Entero Therapeutics, Inc. has announced through a press release by CEO James Sapirstein a letter to its shareholders. The communication, which is not considered filed under SEC regulations, provides updates without becoming part of the company’s formal SEC filings. This move aims to keep shareholders informed without adding to the company’s legal filings.
See more insights into ENTO stock on TipRanks’ Stock Analysis page.